Upwind Secures $300 Million in Latest Funding Round

Upwind secured $300 million in its latest funding round, adding another data point to the Healthcare & Life Sciences funding market.

Upwind Raises $300 million in Funding

Upwind raises $300 million, more than doubles valuation to $3.8 billion in five months. An Israeli biotech is betting they can "If you're building a frontier technology, then you don't have growth" Upwind founder Amiram Shachar.

Investors Behind the Funding

The round was backed by Bessemer Venture Partners. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Upwind operates in Healthcare & Life Sciences. Upwind's financing adds to recent private-market activity.

Strategic Use of Funds

Hit $50 million to $60 million by mid-2026, up from under $20 million at the end of 2025.

Looking Ahead

Upwind raises $300 million, more than doubles valuation to $3.8 billion in five months

Source reference: original announcement/article.